The State of Innovation in Europe

Written by Daniel Chancellor,
Thought Leadership and Consulting Director, Citeline

Overview

Europe’s position as an exporter of scientific innovation is slowly eroding, leaving the risk of the pharmaceutical industry being increasingly molded in the image of more competitive regions.

This white paper discusses the current state of innovation in Europe, from pipeline constitution to emerging drug modalities, R&D alliances to financing trends. While Europe may no longer match the US in scale, and find its position challenged by emerging markets, it has a central role in partnering and possesses notable structural and scientific strengths.

The narrative is supported by data and analysis from Citeline’s proprietary, gold-standard industry sources, including Pharmaprojects and Biomedtracker.

DOWNLOAD NOW

Country *

First Name *

Surname *

Company Name

Email *

Please tick these boxes if you do not wish to receive marketing information relevant to you from EBD Group

via Email

via Telephone

via Post

Please tick this box if you do not wish to be included on our third party mailing list to receive any related marketing communications from our third party partners